One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients

por Körper, Sixten, Grüner, Beate, Zickler, Daniel, Wiesmann, Thomas, Wuchter, Patrick, Blasczyk, Rainer, Zacharowski, Kai, Spieth, Peter, Tonn, Torsten, Rosenberger, Peter, Paul, Gregor, Pilch, Jan, Schwäble, Joachim, Bakchoul, Tamam, Thiele, Thomas, Knörlein, Julian, Dollinger, Matthias M., Krebs, Jörg, Bentz, Martin, Corman, Victor M., Kilalic, Dzenan, Schmidtke-Schrezenmeier, Gerlinde, Lepper, Philipp M., Ernst, Lucas, Wulf, Hinnerk, Ulrich, Alexandra, Weiss, Manfred, Kruse, Jan Matthias, Burkhardt, Thomas, Müller, Rebecca, Klüter, Harald, Schmidt, Michael, Jahrsdörfer, Bernd, Lotfi, Ramin, Rojewski, Markus, Appl, Thomas, Mayer, Benjamin, Schnecko, Philipp, Seifried, Erhard, Schrezenmeier, Hubert
Publicado 2022